From: SYNJ2BP inhibits tumor growth and metastasis by activating DLL4 pathway in hepatocellular carcinoma
Variables | n | Univariable Analysis | Â | Multivariable Analysis | |
---|---|---|---|---|---|
HR (95% CI) | P Value a | HR (95% CI) | P Value a | ||
Gender | Â | Â | Â | Â | Â |
 Male | 14 | 1 |  |  |  |
 Female | 84 | 0.820(0.390-1.727) | 0.602 |  | n.a. |
Age (years) | Â | Â | Â | Â | Â |
 >60 | 27 | 1 |  |  |  |
 ≤60 | 71 | 0.815(0.456-1.456) | 0.490 |  | n.a. |
Hepatitis B status | Â | Â | Â | Â | Â |
 Negative | 17 | 1 |  |  |  |
 Positive | 81 | 0.982(0.496-1.942) | 0.958 |  | n.a. |
AFP(ng/ml) | Â | Â | Â | Â | Â |
 ≥20 | 70 | 1 |  |  |  |
 <20 | 28 | 0.941(0.549-1.612) | 0.824 |  | n.a. |
Liver cirrhosis | Â | Â | Â | Â | Â |
 Absent | 17 | 1 |  |  |  |
 Present | 81 | 0.606(0.329-1.118) | 0.109 |  | n.a. |
Tumor size (cm) | Â | Â | Â | Â | Â |
 ≤3 | 36 | 1 |  | 1 |  |
 > 3 | 62 | 2.998(1.714-5.244) | <0.001 | 0.901(0.543-1.496) | 0.687 |
Number of tumors | Â | Â | Â | Â | Â |
 Single | 47 | 1 |  | 1 |  |
 Multiple (≥ 2) | 51 | 2.772(1.632-4.707) | <0.001 | 1.004(0.479-2.106) | 0.991 |
Vascular invasion | Â | Â | Â | Â | Â |
 Absent | 45 | 1 |  | 1 |  |
 Present | 53 | 2.631(1.570-4.410) | <0.001 | 1.758(1.313-2.353) | <0.001 |
Child-Pugh classification | Â | Â | Â | Â | Â |
 A | 76 | 1 |  |  |  |
 B | 22 | 0.862(0.459-1.617) | 0.643 |  | n.a. |
Edmondson-Steiner grade | Â | Â | Â | Â | Â |
 I-II | 72 | 1 |  |  |  |
 III-IV | 26 | 0.984(0.573-1.688) | 0.952 |  | n.a. |
TNM stage | Â | Â | Â | Â | Â |
 I/ II | 49 | 1 |  | 1 |  |
 III | 49 | 2.003(1.490-2.692) | <0.001 | 0.861(0.507-1.463) | 0.580 |
BCLC | Â | Â | Â | Â | Â |
 0-A | 54 | 1 |  | 1 |  |
 B/C | 44 | 1.818(1.381-2.394) | <0.001 | 2.118(1.177-3.814) | 0.012 |
SYNJ2BP expression | Â | Â | Â | Â | Â |
 Low | 39 | 1 |  | 1 |  |
 High | 59 | 0.216(0.122-0.384) | <0.001 | 0.279(0.125-0.620) | 0.002 |